跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
GEMCITABINA HIKMA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
GEMCITABINA HIKMA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 15, 2020
Approval ID
c95e874b3e75a4b6
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
c95e874b3e75a4b6
Drug Cima Aemps Name
GEMCITABINA HIKMA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
85642
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2020-12-15
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
200 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Active Ingredients
GEMCITABINA HIDROCLORURO
228 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 15, 2020
Approval ID
c95e874b3e75a4b6
Type
Standard
Back to CIMA-AEMPS Approvals
GEMCITABINA HIKMA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details